Publications
P308
Gut Microbes, 2026, 18, 1.
Pre-existing β-lactamase gene diversity is associated with lower risk of ESBL-producing Enterobacterales colonization in patients exposed to ceftriaxone.
https://doi.org/10.1080/19490976.2026.2627692
P307
Journal of Applied Microbiology, 2026, 137, 3, lxag041.
Evaluation of Escherichia coli as a prophylactic treatment of intestinal colonization by extended-spectrum beta-lactamase-producing E. coli in a murine model of antibiotic-induced dysbiosis.
https://doi.org/10.1093/jambio/lxag041
P277
Gut Microbes 2024, 16, 2347021.
Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.
https://doi.org/10.1080/19490976.2024.2347021
P274
J. Appl. Microbiol. 2023, lxad223.
Pantoprazole promotes sustained intestinal carriage of multi-drug resistant Escherichia coli in amoxicillin-treated mice.
https://doi.org/10.1093/jambio/lxad223
P259
Appl. Microbiol. 2022, 132, 2270–2279.
In vitro and in vivo activity of new strains of Bacillus subtilis against ESBL‐producing Escherichia coli: an experimental study.
https://doi.org/10.1111/jam.15329
Autres publications scientifiques
PS34
Clin. Microbiol. Infect. 2024, 30, 1384-1407
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists).
https://doi.org/10.1016/j.cmi.2024.05.014
Brevets
Thèse